• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1.0 和 1.5 毫米硅胶管治疗鼻泪管阻塞的疗效比较。

Comparison of the efficacies of 1.0 and 1.5 mm silicone tubes for the treatment of nasolacrimal duct obstruction.

机构信息

Department of Ophthalmology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.

Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, 236-0004, Japan.

出版信息

Sci Rep. 2022 Jul 11;12(1):11785. doi: 10.1038/s41598-022-16018-4.

DOI:10.1038/s41598-022-16018-4
PMID:35821075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9276691/
Abstract

This retrospective observational study analyzed the postoperative outcomes of bicanalicular intubation using different diameters of tube stents for treating postsaccal nasolacrimal duct obstruction. A total of 130 patients diagnosed with postsaccal obstruction who underwent endoscopic-assisted silicone tube intubation were included in the study. Patients intubated with a 1.5-mm large-diameter tube were designated as the LD group, and those with a 1.0-mm normal-diameter tube were designated as the ND group. The patency rates of the two groups at 1 year after tube removal were compared using the Kaplan-Meier curve and restricted mean survival time (RMST) method with τ = 365 days. Results demonstrated that the recurrence rate after tube removal was significantly lower in the LD group as compared with the ND group (p = 0.001). The patency rates at 1 year after removal in the LD and ND group were 85.7% (95% confidence interval [CI]: 75.4, 91.9) and 73.9% (95% CI: 61.7, 82.8), respectively. When comparing the patency rates by the RMST method at τ = 365 days, the RMST difference, RMST ratio, and RMTL ratio were higher in the LD group at p = 0.045, 0.052, and 0.046, respectively.

摘要

本回顾性观察研究分析了使用不同直径的管支架对治疗泪囊后段鼻泪管阻塞进行双管插管的术后结果。研究共纳入 130 例经诊断为泪囊后段阻塞并接受内镜辅助硅胶管插管的患者。使用 1.5mm 大直径管插管的患者被指定为 LD 组,使用 1.0mm 正常直径管插管的患者被指定为 ND 组。使用 Kaplan-Meier 曲线和受限平均生存时间(RMST)方法(τ=365 天)比较两组患者在去除管后 1 年的通畅率。结果表明,与 ND 组相比,LD 组去除管后的复发率显著降低(p=0.001)。LD 组和 ND 组在去除管后 1 年的通畅率分别为 85.7%(95%可信区间:75.4,91.9)和 73.9%(95%可信区间:61.7,82.8)。通过 RMST 方法比较在 τ=365 天时的通畅率,LD 组的 RMST 差异、RMST 比值和 RMTL 比值分别在 p=0.045、0.052 和 0.046 时更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/18465fffd562/41598_2022_16018_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/2015074d41c9/41598_2022_16018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/03a824b39012/41598_2022_16018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/5ab4b395aa73/41598_2022_16018_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/00c7837fdb6c/41598_2022_16018_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/582f5350b4e8/41598_2022_16018_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/18465fffd562/41598_2022_16018_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/2015074d41c9/41598_2022_16018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/03a824b39012/41598_2022_16018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/5ab4b395aa73/41598_2022_16018_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/00c7837fdb6c/41598_2022_16018_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/582f5350b4e8/41598_2022_16018_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/9276691/18465fffd562/41598_2022_16018_Fig6_HTML.jpg

相似文献

1
Comparison of the efficacies of 1.0 and 1.5 mm silicone tubes for the treatment of nasolacrimal duct obstruction.1.0 和 1.5 毫米硅胶管治疗鼻泪管阻塞的疗效比较。
Sci Rep. 2022 Jul 11;12(1):11785. doi: 10.1038/s41598-022-16018-4.
2
Comparison of the Efficacies of 0.94 mm and Double Silicone Tubes for Treatment of Canalicular Obstruction.0.94毫米硅胶管与双硅胶管治疗泪小管阻塞的疗效比较
Korean J Ophthalmol. 2017 Feb;31(1):1-8. doi: 10.3341/kjo.2017.31.1.1. Epub 2017 Feb 2.
3
Bicanalicular double silicone stenting in endoscopic dacryocystorhinostomy with lacrimal trephination in distal or common canalicular obstruction.经泪小管切开术的内窥镜鼻腔泪囊吻合术中双泪小管内留置双硅胶管治疗远端或共同泪小管阻塞。
Eur Arch Otorhinolaryngol. 2012 Jun;269(6):1605-11. doi: 10.1007/s00405-011-1845-y. Epub 2011 Dec 1.
4
Transcanalicular Laser-Assisted Dacryocystorhinostomy With Endonasal Augmentation in Primary Nasolacrimal Duct Obstruction: Our Experience.经泪小管激光辅助泪囊鼻腔造口术联合鼻内增强术治疗原发性鼻泪管阻塞:我们的经验
Ophthalmic Plast Reconstr Surg. 2017 Nov/Dec;33(6):408-412. doi: 10.1097/IOP.0000000000000802.
5
Trephination and silicone tube intubation in the treatment of canalicular obstruction.钻孔引流及硅胶管置入术治疗泪小管阻塞
Int Ophthalmol. 2023 Feb;43(2):541-547. doi: 10.1007/s10792-022-02453-9. Epub 2022 Aug 17.
6
Effect of Premature Tube Extrusion for Simple Congenital Nasolacrimal Duct Obstruction: A Comparison of Monocanalicular and Bicanalicular Intubation.单纯性先天性鼻泪管阻塞行探通术后过早拔管的效果:单通道与双通道置管的比较。
J Craniofac Surg. 2022;33(1):211-213. doi: 10.1097/SCS.0000000000007915.
7
The outcome of silicone intubation and tube removal in external dacryocystorhinostomy patients with distal canalicular obstruction.远端泪小管阻塞的外路泪囊鼻腔吻合术患者硅胶插管及拔管的结果
Eur J Ophthalmol. 2012 Nov-Dec;22(6):878-81. doi: 10.5301/ejo.5000128. Epub 2012 Feb 27.
8
[Recanalisation by Probing with a Bicanalicular Silicone Tube (Oggel Silicone Intubation) in Patients with Acquired Lacrimal Stenosis].[采用双泪小管硅胶管探通术(奥格尔硅胶插管术)对获得性泪道狭窄患者进行再通治疗]
Klin Monbl Augenheilkd. 2020 Sep;237(9):1093-1101. doi: 10.1055/a-1140-7124. Epub 2020 Jul 13.
9
Retrospective analysis of silicon intubation by Ritleng probe and Sutupak suture fixed in silicone tube in congenital nasolacrimal duct obstruction.回顾性分析先天性鼻泪管阻塞中采用 Ritleng 探针和 Sutupak 缝线固定在硅胶管中的硅管插管。
Indian J Ophthalmol. 2021 Aug;69(8):2095-2098. doi: 10.4103/ijo.IJO_3508_20.
10
Bicanalicular Silicone Intubation for the Management of Punctal Stenosis and Obstruction in Patients With Allergic Conjunctivitis.双管硅胶插管治疗过敏性结膜炎患者的泪点狭窄和阻塞。
Ophthalmic Plast Reconstr Surg. 2019 Sep/Oct;35(5):451-455. doi: 10.1097/IOP.0000000000001315.

引用本文的文献

1
Clinical outcomes and prognostic factors in patients with nasolacrimal duct obstruction or stenosis using dacryoendoscopy.泪道内镜下治疗鼻泪管阻塞或狭窄的临床疗效及预后因素分析。
BMJ Open Ophthalmol. 2024 Oct 31;9(1):e001743. doi: 10.1136/bmjophth-2024-001743.
2
Comparative study of surgical outcomes regarding tear meniscus area and high-order aberrations between two different interventional methods for primary acquired nasolacrimal duct obstruction.两种不同方法治疗原发性鼻泪管阻塞的泪膜半月板面积和高阶像差的手术效果比较研究。
Jpn J Ophthalmol. 2024 Mar;68(2):139-145. doi: 10.1007/s10384-024-01050-w. Epub 2024 Mar 19.
3

本文引用的文献

1
Improvement in Dacryoendoscopic Visibility after Image Processing Using Comb-Removal and Image-Sharpening Algorithms.使用去噪和图像锐化算法进行图像处理后泪道内镜可视性的改善
J Clin Med. 2022 Apr 7;11(8):2073. doi: 10.3390/jcm11082073.
2
Long-term Efficacy of Dacryoendoscopy-guided Recanalization and Silicone Tube Intubation.泪道内窥镜引导下再通和硅胶管插管的长期疗效。
Korean J Ophthalmol. 2022 Jun;36(3):185-193. doi: 10.3341/kjo.2021.0117. Epub 2022 Jan 24.
3
Outcomes of bicanalicular nasal stent inserted by sheath-guided dacryoendoscope in patients with lacrimal passage obstruction: a retrospective observational study.
Long-term outcomes of laser dacryoplasty combined with intubation using a new silicon tube in patients with lacrimal duct obstruction.
新型硅胶管置入联合激光泪囊成形术治疗泪道阻塞患者的长期疗效
Int J Ophthalmol. 2023 Sep 18;16(9):1475-1481. doi: 10.18240/ijo.2023.09.14. eCollection 2023.
泪道阻塞患者经鞘引导泪道内窥镜插入双泪小管鼻腔支架的疗效:一项回顾性观察研究。
BMC Ophthalmol. 2021 Feb 25;21(1):103. doi: 10.1186/s12886-020-01678-5.
4
Transcanalicular endoscopic dacryoplasty in patients with primary acquired nasolacrimal duct obstruction.经鼻内窥镜下泪囊鼻腔吻合术治疗原发性鼻泪管阻塞。
Graefes Arch Clin Exp Ophthalmol. 2021 Jan;259(1):173-180. doi: 10.1007/s00417-020-04833-2. Epub 2020 Aug 3.
5
Changes of Visual Symptoms and Functions in Patients with and without Dry Eye after Lacrimal Passage Obstruction Treatment.泪道阻塞治疗后干眼患者和非干眼患者视觉症状和功能的变化。
Curr Eye Res. 2020 Dec;45(12):1590-1597. doi: 10.1080/02713683.2020.1760305. Epub 2020 May 3.
6
Bicanalicular Intubation with the Kaneka Lacriflow for Proximal Lacrimal Drainage System Stenosis.使用钟渊泪液引流管进行双泪小管插管治疗泪道近端狭窄
Clin Ophthalmol. 2020 Mar 23;14:915-920. doi: 10.2147/OPTH.S248423. eCollection 2020.
7
Human Lacrimal Drainage System Reconstruction, Recanalization, and Regeneration.人类泪道系统的重建、再通和再生
Curr Eye Res. 2020 Mar;45(3):241-252. doi: 10.1080/02713683.2019.1580376. Epub 2019 Feb 22.
8
Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction.经鼻内窥镜下先天性鼻泪管阻塞原发性泪道成形术。
Eye (Lond). 2019 Jun;33(6):1008-1013. doi: 10.1038/s41433-019-0374-6. Epub 2019 Feb 19.
9
Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer.转移性乳腺癌患者的唑来膦酸给药方案
JAMA Oncol. 2018 Apr 1;4(4):585. doi: 10.1001/jamaoncol.2017.0487.
10
Comparison of the Efficacies of 0.94 mm and Double Silicone Tubes for Treatment of Canalicular Obstruction.0.94毫米硅胶管与双硅胶管治疗泪小管阻塞的疗效比较
Korean J Ophthalmol. 2017 Feb;31(1):1-8. doi: 10.3341/kjo.2017.31.1.1. Epub 2017 Feb 2.